Norris Perne & French’s Incyte INCY Stock Holding History

Norris Perne & French’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,500	Closed	-$201K	–	155
2017 Q1	$201K	Buy	+1,500	New	+$191K	0.04%	149

Other funds holding INCY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Norris Perne & French's INCY Position: Q2 2017 in Review

Norris Perne & French sold out of Incyte (INCY) in Q2 2017, closing a stake of 1,500 shares — an estimated $201K sold.

Norris Perne & French first reported a position in INCY in Q1 2017 and held it in 1 quarter. The position peaked at $201K in Q1 2017. 493 funds tracked by Wall St. Rank hold INCY as of Q2 2017.

Norris Perne & French reported no remaining Incyte position as of Q2 2017 after selling out during the quarter.
Norris Perne & French sold 1,500 Incyte shares in Q2 2017, an estimated $201K.
Norris Perne & French first reported a position in Incyte in Q1 2017 and held it in 1 quarter.
Norris Perne & French's Incyte position peaked at $201K in Q1 2017.
493 funds tracked by Wall St. Rank held Incyte as of Q2 2017.

Based on Norris Perne & French's 13F filing for Q2 2017, filed 31 Jul 2017.